Department of Biochemistry and Molecular Biology, Shiga University of Medical Science, Shiga, Japan; Department of Urology, Shiga University of Medical Science, Shiga, Japan.
Department of Biochemistry and Molecular Biology, Shiga University of Medical Science, Shiga, Japan.
Biochem Biophys Res Commun. 2020 May 21;526(1):128-134. doi: 10.1016/j.bbrc.2020.03.043. Epub 2020 Mar 18.
Androgen receptor (AR)-negative castration-resistant prostate cancer (CRPC) is highly aggressive and is resistant to most of the current therapies. Bromodomain and extra terminal domain (BET) protein BRD4 binds to super-enhancers (SEs) that drive high expression of oncogenes in many cancers. A BET inhibitor, JQ1, has been found to suppress the malignant phenotypes of prostate cancer cells, however, the target genes of JQ1 remain largely unknown. Here we show that SE-associated genes specific for AR-negative CRPC PC3 cells include genes involved in migration and invasion, and that JQ1 impairs migration and invasion of PC3 cells. We identified a long non-coding RNA, MANCR, which was markedly down-regulated by JQ1, and found that BRD4 binds to the MANCR locus. MANCR knockdown led to a significant decrease in migration and invasion of PC3 cells. Furthermore, RNA sequencing analysis revealed that expression of the genes involved in migration and invasion was altered by MANCR knockdown. In summary, our data demonstrate that MANCR plays a critical role in migration and invasion of PC3 cells.
雄激素受体(AR)阴性去势抵抗性前列腺癌(CRPC)侵袭性强,对大多数现有疗法均具有耐药性。溴结构域和末端外结构域(BET)蛋白 BRD4 与超级增强子(SE)结合,在许多癌症中驱动癌基因的高表达。一种 BET 抑制剂 JQ1 已被发现可抑制前列腺癌细胞的恶性表型,但 JQ1 的靶基因仍知之甚少。本研究表明,AR 阴性 CRPC PC3 细胞中与 SE 相关的特异性基因包括参与迁移和侵袭的基因,而 JQ1 可损害 PC3 细胞的迁移和侵袭能力。我们鉴定了一个长非编码 RNA MANCR,其被 JQ1 显著下调,并发现 BRD4 与 MANCR 基因座结合。MANCR 敲低导致 PC3 细胞的迁移和侵袭能力显著下降。此外,RNA 测序分析显示,MANCR 敲低改变了参与迁移和侵袭的基因的表达。综上所述,我们的数据表明,MANCR 在 PC3 细胞的迁移和侵袭中发挥关键作用。